118 related articles for article (PubMed ID: 19950702)
1. [Expression of EYA2 in non-small cell lang cancer].
Guo JT; Ding LH; Liang CY; Zhou NK; Ye QN
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):528-31. PubMed ID: 19950702
[TBL] [Abstract][Full Text] [Related]
2. [Expression of Smac in Stage I-II non-small cell lung cancer and its clinical significance].
Zhao JM; Zhu ZH; Wu QL; Hou JH; Huang XP; Zhang PY; Rong TH
Ai Zheng; 2006 May; 25(5):631-4. PubMed ID: 16687088
[TBL] [Abstract][Full Text] [Related]
3. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
[TBL] [Abstract][Full Text] [Related]
4. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.
Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S
Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370
[TBL] [Abstract][Full Text] [Related]
6. The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis.
Wang J; Zhao W; Guo Y; Zhang B; Xie Q; Xiang D; Gao J; Wang B; Chen Z
Oncology; 2009; 76(6):420-9. PubMed ID: 19420963
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
8. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
Chang YS; Kong G; Sun S; Liu D; El-Naggar AK; Khuri FR; Hong WK; Lee HY
Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592
[TBL] [Abstract][Full Text] [Related]
10. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
[TBL] [Abstract][Full Text] [Related]
11. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
13. [Expression of HDGF and its implication in stage I non-small cell lung cancer].
Zhou SJ; Xu SF; Zhang HQ; Liu ZD
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):927-30. PubMed ID: 18478933
[TBL] [Abstract][Full Text] [Related]
14. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer.
Shibahara K; Sugio K; Osaki T; Uchiumi T; Maehara Y; Kohno K; Yasumoto K; Sugimachi K; Kuwano M
Clin Cancer Res; 2001 Oct; 7(10):3151-5. PubMed ID: 11595709
[TBL] [Abstract][Full Text] [Related]
15. [Expression of PKB protein in human squamous-cell carcinoma and adenocarcinoma of lung].
Liao YD; Long QH; Zhou S; Zhao JP; Huang Q; Fu XN
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):156-9. PubMed ID: 15946565
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer.
Zhang S; Qiu X; Gu Y; Wang E
Lung Cancer; 2008 Dec; 62(3):295-301. PubMed ID: 18571765
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
[TBL] [Abstract][Full Text] [Related]
18. Expression of telomeric repeat binding factor 1 in non-small cell lung cancer.
Hu J; Sun L; Zhang C; Zhou X
J Surg Oncol; 2006 Jan; 93(1):62-7. PubMed ID: 16353195
[TBL] [Abstract][Full Text] [Related]
19. A correlation study between maximum standardized uptake values and pathology and clinical staging in nonsmall cell lung cancer.
Lu P; Yu L; Li Y; Sun Y
Nucl Med Commun; 2010 Jul; 31(7):646-51. PubMed ID: 20545045
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
